LBX Pharmacy Chain JSC
SSE:603883
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CN |
LBX Pharmacy Chain JSC
SSE:603883
|
21.3B CNY | 0.9 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
74.6B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.6B USD | 0.1 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
45.5B BRL | 1.3 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
46.6B CNY | 2 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
945B JPY | 0.9 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.4B SAR | 2 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
77.3B MXN | 0.7 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.3B CNY | 1 | |
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
545.1B JPY | 0.6 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.